Vascular Imaging Market by Product Type, Application, End User - Global Forecast to 2030
상품코드:1876463
리서치사:MarketsandMarkets
발행일:2025년 11월
페이지 정보:영문 276 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 혈관 이미징 시장 규모는 2025년 31억 9,000만 달러에서 예측 기간 동안 CAGR 7.3%로 추이하고, 2030년에는 45억 4,000만 달러에 이를 것으로 예측됩니다.
심혈관 질환 증가, 조기 및 정밀 진단의 필요성, 혈관 질환의 위험이 높은 노인 인구의 확대가 혈관 이미징 시장의 성장을 뒷받침하고 있습니다. 3D 이미징, AI를 활용한 진단, 비침습 기술 등의 기술 혁신에 의해 진단의 정밀도와 효율이 향상되어 보다 광범위한 도입이 진행되고 있습니다.
조사 범위
조사 대상 기간
2024-2030년
기준 연도
2024년
예측 기간
2025-2030년
대상 단위
금액(달러)
부문
제품 유형, 용도, 최종 사용자, 지역
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카
게다가 특히 신흥경제국에서는 의료투자 증가, 인프라의 개선, 예방의료에 대한 중점적인 대처가 진행되고 있는 것이 시장 확대에 크게 기여하고 있습니다.
"제품 유형별로 시스템 및 콘솔 부문이 예측 기간 동안 최대 CAGR을 기록할 전망"
이는 혈관 내 초음파(IVUS), 광간섭 단층계(OCT), 근적외선 분광법(NIRS) 등의 고급 이미징 양식을 가능하게하는 핵심 플랫폼 역할을 하기 때문입니다. 이 시스템은 정확한 진단 및 가이드 개입에 필수적인 고해상도 실시간 시각화를 제공하여 병원, 외래수술센터(ASC) 및 전문 클리닉 수요를 견인하고 있습니다. AI와의 통합, 강화된 영상 소프트웨어, 하이브리드 이미징 기능 등의 지속적인 기술 혁신은 임상적 유용성과 채용을 촉진하고 있습니다. 또한 호환 가능한 카테터와 액세서리의 지속적인 수익은 시장 성장을 더욱 가속화하고 시스템과 콘솔은 제조업체에게 중요한 투자 대상이되었습니다.
"용도별로는 2024년 혈관염 부문이 가장 높은 CAGR을 기록"
이 배경은 이환율 증가와 혈관 내 염증을 정확하게 진단 및 모니터링하는 중요성이 높아지고 있다는 것을 들 수 있습니다. PET, MRI, CT 혈관조영 등의 영상 진단 기술의 진보에 의해 혈관염의 조기 단계에서의 검출 및 평가 능력이 대폭 향상되어, 시기 적절하고 표적을 좁힌 치료가 가능하게 되었습니다. 게다가, 혈관염 관리에서 혈관 이미징의 중요성에 대한 임상가의 인식 증가와 고급 영상 기술에 대한 투자 증가가 시장 성장을 가속화하고 있습니다. 혈관염의 만성적 성질과 심각한 합병증을 유발할 가능성은 고급 혈관 이미징 솔루션에 대한 수요를 더욱 강조하고 이 분야의 견조한 확대를 뒷받침하고 있습니다.
"예측 기간 중 아시아태평양이 가장 높은 성장률을 기록할 전망"
아시아태평양은 고령화에 따른 심혈관 질환 증가, 앉기 쉬운 생활 습관, 당뇨병 및 고혈압의 유병률 상승을 배경으로 혈관 이미징 시장에서 가장 높은 CAGR을 나타낼 것으로 예측되고 있습니다. 의료 인프라에 대한 대규모 투자, 조기 진단을 촉진하는 정부 프로그램, 첨단 영상 기술의 급속한 보급이 수요를 더욱 강화하고 있습니다. 또한 의료비 지출 증가, 저렴한 영상 진단 솔루션에 대한 수요, 중국과 인도와 같은 주요 경제 지역에서 AI 기반 도구의 통합이 이 지역 시장 성장을 강력하게 추진하고 있습니다.
본 보고서에서는 세계의 혈관 이미징 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 기술 및 특허 동향, 법규제 환경, 사례 연구, 시장 규모 추이와 예측, 각종 구분 및 지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
The global vascular imaging market is projected to reach USD 4.54 billion by 2030 from USD 3.19 billion in 2025, growing at a CAGR of 7.3% during the forecast period. The growth in the vascular imaging market is fueled by the increasing burden of cardiovascular diseases, the need for early and precise diagnosis, and the expanding elderly population vulnerable to vascular conditions. Advances in technology, including 3D imaging, AI-powered diagnostics, and non-invasive techniques, are enhancing accuracy and efficiency, driving wider adoption.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD billion)
Segments
Product Type, Application, End User, and Region
Regions covered
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Furthermore, rising healthcare investments, improved infrastructure, and greater emphasis on preventive care, especially across emerging economies, are contributing significantly to the market's expansion.
By product type, the systems & consoles segment is expected to register the highest CAGR during the forecast period.
By product type, the systems & consoles segment is expected to account for the highest CAGR in the vascular imaging market because they serve as the core platforms enabling advanced imaging modalities such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS). These systems provide high-resolution, real-time visualization critical for accurate diagnosis and guided interventions, driving demand in hospitals, ambulatory surgery centers, and specialty clinics. Continuous technological innovations-such as integration with AI, enhanced imaging software, and hybrid imaging capabilities-boost their clinical utility and adoption. Additionally, recurring revenue from compatible catheters and accessories further propels market growth, making systems and consoles a key investment focus for manufacturers.
By application, the vasculitis segment accounted for the highest CAGR of the market in 2024.
In the vascular imaging market, the vasculitis segment dominated the market due to its increasing prevalence and the critical need for accurate diagnosis and monitoring of inflammation in blood vessels. Advances in imaging technologies such as PET, MRI, and CT angiography have significantly improved the ability to detect and assess vasculitis at early stages, enabling timely and targeted treatment. Additionally, growing awareness among clinicians about the importance of vascular imaging in managing vasculitis, coupled with rising investment in advanced imaging modalities, is accelerating market growth. The chronic nature of vasculitis and its potential to cause severe complications further underscores the demand for sophisticated vascular imaging solutions, fueling robust expansion in this segment.
Asia Pacific is expected to register the highest growth rate in the market during the forecast period.
The Asia-Pacific region is expected to register the highest CAGR in the vascular imaging market, driven by the growing burden of cardiovascular diseases linked to an aging population, sedentary lifestyles, and the increasing prevalence of diabetes and hypertension. Significant investments in healthcare infrastructure, government programs promoting early diagnosis, and the rapid adoption of advanced imaging technologies are further fueling demand. Additionally, rising healthcare spending, the need for affordable imaging solutions, and the integration of AI-based tools across major economies such as China and India are propelling the region's strong market growth.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
By Designation: C-level Executives (55%), Directors (27%), and Others (18%)
By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%)
The prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), Shenzhen Mindray Bio-Medical Electronics (China), FUJIFILM Corporation (Japan), Hologic Inc. (US), Samsung Electronics Co., Ltd. (South Korea), Shimadzu Corporation (Japan), United Imaging Healthcare (China), Konica Minolta (Japan), Neusoft Corporation (China), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), Nipro Europe Group Companies (Belgium).
Research Coverage
The vascular imaging market is segmented by product type, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Vascular imaging market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions.
Key Benefits of Buying the Report
The report is valuable for new entrants in the vascular imaging market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report provides insights into both key and smaller players in the market, which can help create a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis.
The report provides insights into the following points:
Key drivers (rising prevalence of cardiovascular diseases, minimally invasive and personalized interventions, technological advancements in vascular imaging technology, increasing investments, funds, and grants by public-private organizations), restraints (radiation exposure and contrast-related risks, unfavorable reimbursement scenario, high costs and resource requirements), opportunities (expanding economies offer high growth potential, increasing establishment of hospitals and diagnostic imaging centers, increasing adoption of teleradiology), and challenges (hospital budget cuts, increasing adoption of refurbished diagnostic imaging systems, dearth of trained professionals, image quality limitations because of patient and physiological motion) fueling the market growth of vascular imaging market.
Product Development/Innovation: Emerging technologies in space, R&D, recent product launches & approvals in the vascular imaging market.
Market Growth: In-depth insights into remunerative markets report analyze the vascular imaging market across varied geographies.
Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the vascular imaging market
Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), and FUJIFILM Corporation (Japan), among others.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION APPROACH
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
